Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Times Interest Earned (2016 - 2025)

China Pharma Holdings filings provide 16 years of Times Interest Earned readings, the most recent being -$174.47 for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 0.78% to -$174.47 in Q4 2025 year-over-year; TTM through Dec 2025 was -$118.9, a 29.13% increase, with the full-year FY2025 number at -$118.77, up 29.2% from a year prior.
  • Times Interest Earned hit -$174.47 in Q4 2025 for China Pharma Holdings, down from -$92.4 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $5.56 in Q4 2021 to a low of -$225.1 in Q3 2021.
  • Median Times Interest Earned over the past 5 years was -$99.49 (2023), compared with a mean of -$95.29.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 97.59% in 2023 and later crashed 6026.77% in 2024.
  • China Pharma Holdings' Times Interest Earned stood at $5.56 in 2021, then plummeted by 203.45% to -$5.75 in 2022, then surged by 45.12% to -$3.16 in 2023, then crashed by 5472.43% to -$175.84 in 2024, then grew by 0.78% to -$174.47 in 2025.
  • The last three reported values for Times Interest Earned were -$174.47 (Q4 2025), -$92.4 (Q3 2025), and -$96.2 (Q2 2025) per Business Quant data.